Johnson & Johnson and its Janssen Pharmaceuticals subsidiary have to face yet another product liability lawsuit filed by a man from Texas for undergoing transmetatarsal and guillotine amputations of the right foot above the ankle. The plaintiff holds the defendants responsible for not adequately warning the users and the medical community about a large number of leg and foot amputation problems linked with Invokana.The case was filed in the U.S. District Court for the District of New Jersey.
Invokana: MDL 2750, in re: Invokana (Canagliflozin) Products Liability Litigation) was created in December 2016 and is presided by Hon. Brian R. Martinotti, in the U.S. District Court for the District of New Jersey; the first bellwether is scheduled for September 2018. Cases are also filed in state courts, primarily in California, Pennsylvania, and New Jersey.
More than 1,000 Invokana lawsuits are currently pending the federal MDL and undergoing pretrial discovery phase.
